Harnessing the power of real-world data to drive more effective decision making in oncology clinical trials
By Fortrea
Download this paper now to learn in detail how Natural History studies draw on retrospective data from registries, diagnostics and patient records to track diseases without trial-specific interventions.
Discover how this helps drug developers to better understand disease progression treatment responses, and market availability, ultimately helping to design more efficient trials, enhancing patient engagement and faster regulatory review.